OGIVRI® is available in Single (150mg) and multi-dose (420mg)
vials
May reduce wastage and provide flexibility to choose the right
dosage form for individual practices
Register now
Connect with us for news and updates related to OGIVRI® (trastuzumab-dkst) injection.
*All fields required
You are now leaving ogivrihcp.com a Biocon Biologics Inc. company website.
The website you are about to access is not owned or controlled by Biocon Biologics. Links to other websites are provided as a convenience to users and the inclusion of any link does not imply the endorsement of the linked site by Biocon Biologics. Biocon Biologics accepts no responsibility for the content of any linked sites.